BINV — BioInvent International AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK1.09bn
- SEK41.63m
- SEK71.46m
- 16
- 18
- 35
- 11
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -138 | -75.5 | -278 | -50.9 | -370 |
Depreciation | |||||
Non-Cash Items | 0.379 | -0.041 | 1.14 | 1.79 | 2.95 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.43 | 0.889 | 16.8 | -5.94 | 11.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -125 | -62.6 | -246 | -40.3 | -338 |
Capital Expenditures | -3.84 | -6.7 | -13.3 | -12.4 | -13.3 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -454 | -616 | 73 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -3.84 | -6.7 | -468 | -629 | 59.7 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 214 | 645 | 895 | 273 | 23.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 85.1 | 575 | 181 | -396 | -255 |